121 related articles for article (PubMed ID: 8843149)
1. Tamoxifen retards glycosphingolipid metabolism in human cancer cells.
Cabot MC; Giuliano AE; Volner A; Han TY
FEBS Lett; 1996 Sep; 394(2):129-31. PubMed ID: 8843149
[TBL] [Abstract][Full Text] [Related]
2. Agents that reverse multidrug resistance, tamoxifen, verapamil, and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells.
Lavie Y; Cao Ht; Volner A; Lucci A; Han TY; Geffen V; Giuliano AE; Cabot MC
J Biol Chem; 1997 Jan; 272(3):1682-7. PubMed ID: 8999846
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance modulators and doxorubicin synergize to elevate ceramide levels and elicit apoptosis in drug-resistant cancer cells.
Lucci A; Han TY; Liu YY; Giuliano AE; Cabot MC
Cancer; 1999 Jul; 86(2):300-11. PubMed ID: 10421266
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of glucosylceramides in multidrug-resistant cancer cells.
Lavie Y; Cao H; Bursten SL; Giuliano AE; Cabot MC
J Biol Chem; 1996 Aug; 271(32):19530-6. PubMed ID: 8702646
[TBL] [Abstract][Full Text] [Related]
7. Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase.
Nicholson KM; Quinn DM; Kellett GL; Warr JR
Br J Cancer; 1999 Oct; 81(3):423-30. PubMed ID: 10507766
[TBL] [Abstract][Full Text] [Related]
8. Glycosphingolipids of human KB cells grown in monolayer, suspension, and synchronized cultures.
Chatterjee S; Sweeley CC; Velicer LF
J Biol Chem; 1975 Jan; 250(1):61-6. PubMed ID: 1141212
[TBL] [Abstract][Full Text] [Related]
9. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
Morad SA; Cabot MC
Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by N-hexanoylsphingosine in CHP-100 cells associates with accumulation of endogenous ceramide and is potentiated by inhibition of glucocerebroside synthesis.
Spinedi A; Bartolomeo SD; Piacentini M
Cell Death Differ; 1998 Sep; 5(9):785-91. PubMed ID: 10200538
[TBL] [Abstract][Full Text] [Related]
12. Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets.
Morjani H; Aouali N; Belhoussine R; Veldman RJ; Levade T; Manfait M
Int J Cancer; 2001 Oct; 94(2):157-65. PubMed ID: 11668492
[TBL] [Abstract][Full Text] [Related]
13. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
14. Glucosylceramide: a marker for multiple-drug resistant cancers.
Lucci A; Cho WI; Han TY; Giuliano AE; Morton DL; Cabot MC
Anticancer Res; 1998; 18(1B):475-80. PubMed ID: 9568165
[TBL] [Abstract][Full Text] [Related]
15. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
Zador IZ; Deshmukh GD; Kunkel R; Johnson K; Radin NS; Shayman JA
J Clin Invest; 1993 Mar; 91(3):797-803. PubMed ID: 8450061
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of sugar incorporation into glycosphingolipids and glycoproteins.
Paul P; Bordmann A; Rosenfelder G; Towbin H
Anal Biochem; 1992 Aug; 204(2):265-72. PubMed ID: 1443524
[TBL] [Abstract][Full Text] [Related]
17. Regulation of glycosphingolipid metabolism in liver during the acute phase response.
Memon RA; Holleran WM; Uchida Y; Moser AH; Ichikawa S; Hirabayashi Y; Grunfeld C; Feingold KR
J Biol Chem; 1999 Jul; 274(28):19707-13. PubMed ID: 10391911
[TBL] [Abstract][Full Text] [Related]
18. Altered sphingolipid metabolism in multidrug-resistant ovarian cancer cells is due to uncoupling of glycolipid biosynthesis in the Golgi apparatus.
Veldman RJ; Klappe K; Hinrichs J; Hummel I; van der Schaaf G; Sietsma H; Kok JW
FASEB J; 2002 Jul; 16(9):1111-3. PubMed ID: 12039850
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity.
Aerts JM; Ottenhoff R; Powlson AS; Grefhorst A; van Eijk M; Dubbelhuis PF; Aten J; Kuipers F; Serlie MJ; Wennekes T; Sethi JK; O'Rahilly S; Overkleeft HS
Diabetes; 2007 May; 56(5):1341-9. PubMed ID: 17287460
[TBL] [Abstract][Full Text] [Related]
20. Lactosylceramide is synthesized in the lumen of the Golgi apparatus.
Lannert H; Bünning C; Jeckel D; Wieland FT
FEBS Lett; 1994 Mar; 342(1):91-6. PubMed ID: 8143857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
